XML 41 R30.htm IDEA: XBRL DOCUMENT
v3.25.2

Summary of Significant Accounting Policies (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Accounting Policies [Abstract] |
Schedules of Concentration of Credit Risk | Schedules of Concentration of Credit Risk
|  | June 30, 2025 |  |  | December 31, 2024 |
Customer A |  |  | 52 | % |  |  | -* |
Customer B |  |  | 46 | % |  |  | -* |
Customer C |  |  | -* |  |  |  | 36 | %
Customer D |  |  | -* |  |  |  | 17 | %
Customer E |  |  | -* |  |  |  | 15 | %
Concentration risk percentage |  |  | -* |  |  |  | 15 | %
* |  | Accounts Receivable was less than 10%
Schedules of Financial Instruments Fair value Hierarchy | The following table summarizes the Company’s financial instruments at fair value based on the fair value hierarchy for each class of instrument as of June 30, 2025: Schedules of Financial Instruments Fair value Hierarchy
|  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Total |
Convertible notes payable |  | $ | — |  |  | $ | — |  |  | $ | 19,434,004 |  |  | $ | 19,434,004 |
Schedules of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation | The Company calculated the estimated fair value of the convertible notes payable during the six months ended June 30, 2025 using the following assumptions: Schedules of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation
Issuance date |  | 2/10/2025 |
Maturity date |  | 5/10/2026 |
Stock price |  |  | 5.88 - 7.45 |
Expected volatility factor |  |  | 124.8 - 128.3 | %
Risk-free interest rate |  |  | 4.02 - 4.25 | %
Schedules of Changes in Convertible Notes Payable Measured at Fair Value | The following table presents changes in the Level 3 convertible notes payable measured at fair value for the six months ended June 30, 2025: Schedules of Changes in Convertible Notes Payable Measured at Fair Value
Balance, January 1, 2025 |  | $ | — |
Balance |  | $ | — |
Additions |  |  | 14,432,879 |
Fair value measurement adjustments |  |  | 6,864,056 |
Loss on extinguishment |  |  | 4,623,335 |
Redemption |  |  | (1,650,000 | )
Conversion into common stock |  |  | (4,836,266 | )
Balance, June 30, 2025 |  | $ | 19,434,004 |
Balance |  | $ | 19,434,004 |
Schedules of Revenue Disaggregated by Revenue Type | The following table presents the Company’s revenue disaggregated by revenue type: Schedules of Revenue Disaggregated by Revenue Type
|  |  |  |  |  |  |  | 2025 |  |  | 2024 |
|  | Three months ended June 30, |  | Six months ended June 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Product related |  | $ | 2,090,278 |  |  | $ | 3,208,870 |  |  | $ | 3,719,940 |  |  | $ | 9,822,899 |
Contract related |  |  | 1,128,299 |  |  |  | 3,210,799 |  |  |  | 1,128,299 |  |  |  | 3,210,799 |
Total |  | $ | 3,218,577 |  |  | $ | 6,419,669 |  |  | $ | 4,848,239 |  |  | $ | 13,033,698 |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
|  | June 30, 2025 |  |  | December 31, 2024 |
Series B Preferred Stock, as converted |  |  | 3,896 |  |  |  | 3,896 |
Stock options |  |  | 5,317,060 |  |  |  | 5,242,308 |
Warrants |  |  | 1,631,433 |  |  |  | 914,056 |
Restricted stock |  |  | 2,009,841 |  |  |  | 1,544,027 |
Total |  |  | 8,962,230 |  |  |  | 7,704,287 |

X
- Definition Tabular disclosure of revenue recognition disaggregated revenue. + References No definition available. + Details
Name: | RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock
Namespace Prefix: | RCAT_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of financial instrument measured at fair value on recurring or nonrecurring basis. Includes, but is not limited to, instrument classified in shareholders' equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration